Immune Priming of the Tumor Microenvironment by Radiation

被引:128
作者
Jiang, Wen [1 ]
Chan, Charles K. [2 ]
Weissman, Irving L. [2 ]
Kim, Betty Y. S. [3 ,4 ,5 ]
Hahn, Stephen M. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[3] Mayo Clin Florida, Dept Canc Biol, Jacksonville, FL 32224 USA
[4] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA
[5] Mayo Clin Florida, Dept Neurosurg, Jacksonville, FL 32224 USA
来源
TRENDS IN CANCER | 2016年 / 2卷 / 11期
关键词
IMMUNOGENIC CELL-DEATH; TGF-BETA; T-CELLS; CANCER; EXPRESSION; BLOCKADE; RADIOTHERAPY; MECHANISMS; RESPONSES; HYPOXIA;
D O I
10.1016/j.trecan.2016.09.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ionizing irradiation can induce a multitude of alterations within the tumor microenvironment. Unlike targeted therapies, radiation delivered to the tumor bed can prompt phenotypic changes in both normal stromal and cancer cells, leading to molecular and physiological alterations within the tumor microenvironment. These environmental modulations directly influence the degree of immunogenicity of the tumor microenvironment and may ultimately affect tumor responsiveness to cancer immunotherapies. Here we review the preclinical evidence for tumor microenvironment-mediated immune suppression and how radiation can modulate immune properties within a tumor. We then discuss the therapeutic opportunities for combining radiation with molecular agents to enhance tumor immunogenicity and how this represents a potential exciting strategy to complement immunotherapies including immune checkpoint blockers in cancer treatment.
引用
收藏
页码:638 / 645
页数:8
相关论文
共 77 条
  • [1] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [2] Targeting the TGF-β1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy
    Anscher, Mitchell S.
    [J]. ONCOLOGIST, 2010, 15 (04) : 350 - 359
  • [3] Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Obeid, Michel
    Ortiz, Carla
    Criollo, Alfredo
    Mignot, Gregoire
    Maiuri, M. Chiara
    Ullrich, Evelyn
    Saulnier, Patrick
    Yang, Huan
    Amigorena, Sebastian
    Ryffel, Bernard
    Barrat, Franck J.
    Saftig, Paul
    Levi, Francis
    Lidereau, Rosette
    Nogues, Catherine
    Mira, Jean-Paul
    Chompret, Agnes
    Joulin, Virginie
    Clavel-Chapelon, Francoise
    Bourhis, Jean
    Andre, Fabrice
    Delaloge, Suzette
    Tursz, Thomas
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. NATURE MEDICINE, 2007, 13 (09) : 1050 - 1059
  • [4] Radiation and the microenvironment - Tumorigenesis and therapy
    Barcellos-Hoff, MH
    Park, C
    Wright, EG
    [J]. NATURE REVIEWS CANCER, 2005, 5 (11) : 867 - 875
  • [5] The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
    Barker, Holly E.
    Paget, James T. E.
    Khan, Aadil A.
    Harrington, Kevin J.
    [J]. NATURE REVIEWS CANCER, 2015, 15 (07) : 409 - 425
  • [6] Cancer - Out of air is not out of action
    Bottaro, DP
    Liotta, LA
    [J]. NATURE, 2003, 423 (6940) : 593 - 595
  • [7] Radiation as an Immune Modulator
    Burnette, Byron
    Weichselbaum, Ralph R.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (04) : 273 - 280
  • [8] Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
    Castriconi, R
    Cantoni, C
    Della Chiesa, M
    Vitale, M
    Marcenaro, E
    Conte, R
    Biassoni, R
    Bottino, C
    Moretta, L
    Moretta, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 4120 - 4125
  • [9] Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
    Chao, Mark P.
    Jaiswal, Siddhartha
    Weissman-Tsukamoto, Rachel
    Alizadeh, Ash A.
    Gentles, Andrew J.
    Volkmer, Jens
    Weiskopf, Kipp
    Willingham, Stephen B.
    Raveh, Tal
    Park, Christopher Y.
    Majeti, Ravindra
    Weissman, Irving L.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (63)
  • [10] PDL1 Regulation by p53 via miR-34
    Cortez, Maria Angelica
    Ivan, Cristina
    Valdecanas, David
    Wang, Xiaohong
    Peltier, Heidi J.
    Ye, Yuping
    Araujo, Luiz
    Carbone, David P.
    Shilo, Konstantin
    Giri, Dipak K.
    Kelnar, Kevin
    Martin, Desiree
    Komaki, Ritsuko
    Gomez, Daniel R.
    Krishnan, Sunil
    Calin, George A.
    Bader, Andreas G.
    Welsh, James W.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (01):